Blood–brain
barrier (BBB)-permeable middle- or macromolecules
(middle/macromolecules) have recently attracted significant attention
as new drug delivery carriers into the human brain via receptor-mediated
transcytosis (RMT). During the development process of such carriers,
it is necessary to thoroughly evaluate their human BBB permeability
levels. In such evaluations, our recently established human immortalized
cell-based multicellular spheroidal BBB models (hiMCS-BBB models)
have shown high potential. However, the specifics of those capabilities
have yet to be elucidated. Therefore, in this study, we characterize
the ability of the hiMCS-BBB models to evaluate RMT-mediated BBB penetration
properties of middle/macromolecules. More specifically, we began by
validating transferrin receptor (TfR)-mediated RMT functionalities
using transferrin in the hiMCS-BBB models and then examined the BBB
permeability levels of MEM189 antibodies (known BBB-permeable anti-TfR
antibodies). The obtained results showed that, as with the case of
transferrin, temperature-dependent uptake of MEM189 antibodies was
observed in the hiMCS-BBB models, and the extent of that uptake increased
in a time-dependent manner until reaching a plateau after around 2
h. To further expand the evaluation applicability of the models, we
also examined the BBB permeability levels of the recently developed
SLS cyclic peptide and observed that peptide uptake was also temperature-dependent.
To summarize, our results show that the hiMCS-BBB models possess the
ability to evaluate the RMT-mediated BBB-permeable properties of antibodies
and peptides and thus have the potential to provide valuable tools
for use in the exploration and identification of middle/macromolecules
showing excellent BBB permeability levels, thereby contributing powerfully
to the development of new drug delivery carriers for transporting
drugs into the human brain.